DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+12.57%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.11B
AUM Growth
+$4.11B
(+20%)
Cap. Flow
-$2.19M
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
37.55%
Holding
126
New
30
Increased
16
Reduced
24
Closed
24
Top Buys
| 1 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$129M |
| 2 |
Nkarta
NKTX
|
$72.7M |
| 3 |
CalciMedica
CALC
|
$67.1M |
| 4 |
Centene
CNC
|
$54.9M |
| 5 |
OSH
Oak Street Health, Inc.
OSH
|
$50.8M |
Top Sells
| 1 |
Schrodinger
SDGR
|
$123M |
| 2 |
Hologic
HOLX
|
$65.3M |
| 3 |
McKesson
MCK
|
$42.7M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$32.3M |
| 5 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$31.2M |
Sector Composition
| 1 | Healthcare | 62.18% |
| 2 | Financials | 1.23% |
| 3 | Industrials | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFHTU
26
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
| $35.7M | 0.87% |
+3,360,000
| New | +$35.7M |
|
27
Glaukos
GKOS
$5.42B
| $34.4M | 0.84% |
695,523
-178,477
| -20% | -$8.84M |
|
|
ISEE
28
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $32.5M | 0.79% |
5,767,409
| – | – |
|
|
INZY
29
DELISTED
Inozyme Pharma
INZY
| $30.2M | 0.74% |
+1,150,299
| New | +$30.2M |
|
30
Generation Bio
GBIO
$40.3M
| $29.7M | 0.72% |
961,215
-225,000
| -19% | -$6.95M |
|
31
Kodiak Sciences
KOD
$453M
| $29.4M | 0.72% |
+497,000
| New | +$29.4M |
|
32
QuidelOrtho
QDEL
$1.87B
| $28.6M | 0.7% |
+130,521
| New | +$28.6M |
|
|
ORTX
33
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $28.6M | 0.7% |
6,949,416
-310,572
| -4% | -$1.28M |
|
34
Puma Biotechnology
PBYI
$258M
| $28.5M | 0.69% |
+2,826,327
| New | +$28.5M |
|
|
BDSI
35
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $28.5M | 0.69% |
7,635,750
+1,090,250
| +17% | +$4.07M |
|
36
Molina Healthcare
MOH
$9.6B
| $28M | 0.68% |
153,000
+32,755
| +27% | +$6M |
|
37
Editas Medicine
EDIT
$225M
| $27.7M | 0.68% |
988,841
-170,000
| -15% | -$4.77M |
|
38
Vericel Corp
VCEL
$1.69B
| $27.6M | 0.67% |
1,490,118
-1,567,043
| -51% | -$29M |
|
|
DCPH
39
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $27.1M | 0.66% |
528,585
+106,906
| +25% | +$5.48M |
|
40
Fate Therapeutics
FATE
$115M
| $26.7M | 0.65% |
668,067
-245,708
| -27% | -$9.82M |
|
41
eHealth
EHTH
$126M
| $26.3M | 0.64% |
+333,411
| New | +$26.3M |
|
42
OraSure Technologies
OSUR
$230M
| $26.3M | 0.64% |
+2,160,983
| New | +$26.3M |
|
|
43
Hologic
HOLX
$14.7B
| $25.8M | 0.63% |
388,000
-982,186
| -72% | -$65.3M |
|
|
XENT
44
DELISTED
Intersect ENT, Inc
XENT
| $25.7M | 0.62% |
1,573,534
-1,003,345
| -39% | -$16.4M |
|
|
VIVO
45
DELISTED
Meridian Bioscience Inc
VIVO
| $25.6M | 0.62% |
1,508,398
-154,602
| -9% | -$2.63M |
|
46
Adverum Biotechnologies
ADVM
$68.2M
| $24.8M | 0.6% |
2,404,439
+1,570,544
| +188% | +$16.2M |
|
|
TCRR
47
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $24.4M | 0.59% |
+1,200,000
| New | +$24.4M |
|
48
Black Diamond Therapeutics
BDTX
$164M
| $24.3M | 0.59% |
802,511
+266,510
| +50% | +$8.06M |
|
|
ACCD
49
DELISTED
Accolade, Inc. Common Stock
ACCD
| $24.3M | 0.59% |
+624,001
| New | +$24.3M |
|
50
American Well
AMWL
$112M
| $23.4M | 0.57% |
+791,115
| New | +$23.4M |
|